ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Rhode Island » Hematology Oncology

Top Hematology Oncology Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MUHAMMAD AKHTAR M.D.

Hematology Oncology

6,322

$417K

240
158 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

27%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 15%

$66
Average prescription price

Avg: $279

JOHN PRZYGODA M.D.

Hematology Oncology

3,429

$524K

318
279 are 65+

8%
patients receiving schedule two controlled substances

Avg: 12%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 15%

$153
Average prescription price

Avg: $279

SUNDARESAN SAMBANDAM M.D.

Hematology Oncology

1,792

$511K

253
200 are 65+

15%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 15%

$285
Average prescription price

Avg: $279

ANTHONY THOMAS D.O.

Hematology Oncology

1,637

$525K

140
113 are 65+

18%
patients receiving schedule two controlled substances

Avg: 12%

16%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 15%

$321
Average prescription price

Avg: $279

PLAKYIL JOSEPH M.D.

Hematology Oncology

1,533

$859K

206
173 are 65+

17%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 15%

$561
Average prescription price

Avg: $279

ABDULSATTAR MEMON M. D.

Hematology Oncology

1,413

$45.2K

147
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 15%

$32
Average prescription price

Avg: $279

ANTHONY TESTA M.D.

Hematology Oncology

1,282

$311K

159
135 are 65+

10%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 15%

$243
Average prescription price

Avg: $279

ROCHELLE STRENGER MD

Hematology Oncology

1,192

$130K

177
156 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

3%
prescriptions for brand name drugs

Avg: 15%

$109
Average prescription price

Avg: $279

AHMED NADEEM MD

Hematology Oncology

1,110

$324K

140
120 are 65+

20%
patients receiving schedule two controlled substances

Avg: 12%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

12%
prescriptions for brand name drugs

Avg: 15%

$292
Average prescription price

Avg: $279

MARY ANNE FENTON M.D.

Hematology Oncology

978

$126K

139
116 are 65+

9%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 15%

$129
Average prescription price

Avg: $279

ANTHONY MEGA MD

Hematology Oncology

919

$733K

133
110 are 65+

18%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 15%

$797
Average prescription price

Avg: $279

HOWARD SAFRAN M.D.

Hematology Oncology

906

$274K

134
116 are 65+

30%
patients receiving schedule two controlled substances

Avg: 12%

13%
patients receiving schedule three controlled substances

Avg: 4%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 15%

$303
Average prescription price

Avg: $279

RAYMOND CHAQUETTE M.D.

Hematology Oncology

844

$223K

130
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 15%

$264
Average prescription price

Avg: $279

RITESH RATHORE MD

Hematology Oncology

842

$393K

97
74 are 65+

28%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 15%

$467
Average prescription price

Avg: $279

ROBERT LEGARE MD

Hematology Oncology

780

$234K

127
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 15%

$301
Average prescription price

Avg: $279

DAVID STOLL

Hematology Oncology

756

$259K

154
118 are 65+

16%
patients receiving schedule two controlled substances

Avg: 12%

10%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 15%

$342
Average prescription price

Avg: $279

ALESSANDRO PAPA M.D.

Hematology Oncology

756

$463K

96
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 15%

$612
Average prescription price

Avg: $279

ROBERT KNISLEY MD

Hematology Oncology

729

$119K

97
82 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 15%

$163
Average prescription price

Avg: $279

SABRINA WITHERBY M.D.

Hematology Oncology

687

$299K

81
70 are 65+

15%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 15%

$435
Average prescription price

Avg: $279

WILLIAM SIKOV MD

Hematology Oncology

685

$186K

105
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 15%

$272
Average prescription price

Avg: $279

ADAM OLSZEWSKI M.D.

Hematology Oncology

659

$67.7K

79
66 are 65+

28%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 15%

$103
Average prescription price

Avg: $279

JAMES BUTERA M.D.

Hematology Oncology

624

$805K

81
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 15%

$1291
Average prescription price

Avg: $279

JAMES SMYTHE MD

Hematology Oncology

622

$209K

105
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 15%

$336
Average prescription price

Avg: $279

EDWARD WITTELS MD

Hematology Oncology

548

$328K

83
70 are 65+

13%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 15%

$599
Average prescription price

Avg: $279

BHARTI RATHORE MD

Hematology Oncology

434

$130K

66
57 are 65+

18%
patients receiving schedule two controlled substances

Avg: 12%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

11%
prescriptions for brand name drugs

Avg: 15%

$298
Average prescription price

Avg: $279

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank